Cantu, E., Suzuki, Y., Diamond, J. M., Shah, R. J., Flesch, J. D., Meyer, N. J., … Christie, J. D. (2013). Plasma PAI-1 Used as a Quantitative Trait Implicates the Innate Immune Regulator TOLLIP in Post Lung Transplant Primary Graft Dysfunction Risk. In The Journal of Heart and Lung Transplantation (Vol. 32, pp. S29–S29). Elsevier BV. https://doi.org/10.1016/j.healun.2013.01.874

Cantu, E., Y. Suzuki, J. M. Diamond, R. J. Shah, J. D. Flesch, N. J. Meyer, D. J. Lederer, et al. “Plasma PAI-1 Used as a Quantitative Trait Implicates the Innate Immune Regulator TOLLIP in Post Lung Transplant Primary Graft Dysfunction Risk.” In The Journal of Heart and Lung Transplantation, 32:S29–S29. Elsevier BV, 2013. https://doi.org/10.1016/j.healun.2013.01.874.

Cantu E, Suzuki Y, Diamond JM, Shah RJ, Flesch JD, Meyer NJ, et al. Plasma PAI-1 Used as a Quantitative Trait Implicates the Innate Immune Regulator TOLLIP in Post Lung Transplant Primary Graft Dysfunction Risk. In: The Journal of Heart and Lung Transplantation. Elsevier BV; 2013. p. S29–S29.

Cantu, E., et al. “Plasma PAI-1 Used as a Quantitative Trait Implicates the Innate Immune Regulator TOLLIP in Post Lung Transplant Primary Graft Dysfunction Risk.” The Journal of Heart and Lung Transplantation, vol. 32, no. 4, Elsevier BV, 2013, pp. S29–S29. Crossref, doi:10.1016/j.healun.2013.01.874.

Cantu E, Suzuki Y, Diamond JM, Shah RJ, Flesch JD, Meyer NJ, Lederer DJ, Kawut SM, Lee JC, Palmer SM, Lama VN, Bhorade SM, Crespo MM, Demissie E, Wille KM, Orens JB, Shah PD, Weinacker A, Weill D, Acrasoy SM, Wilkes DS, Ware LB, Feng R, Christie JD. Plasma PAI-1 Used as a Quantitative Trait Implicates the Innate Immune Regulator TOLLIP in Post Lung Transplant Primary Graft Dysfunction Risk. The Journal of Heart and Lung Transplantation. Elsevier BV; 2013. p. S29–S29.